The Klinique Medical Clinic PCL (BKK:KLINIQ)

BKK:KLINIQ Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	628.02	247.91	108.48	464.44	75.91	9.28
Short-Term Investments	161.23	530.63	1,060	1,000	-	-
Cash & Short-Term Investments	789.25	778.54	1,168	1,464	75.91	9.28
Cash Growth	-9.59%	-33.37%	-20.21%	1829.24%	717.54%	-73.72%
Accounts Receivable	7.95	7.32	12.44	2.88	1.47	0.88
Other Receivables	-	0.04	-	-	-	-
Receivables	7.95	7.36	12.44	2.88	1.47	0.88
Inventory	306.68	271.63	191.09	120.05	84.24	103.1
Prepaid Expenses	29.83	29.46	25.34	17.95	5.57	19.35
Other Current Assets	64.85	57.21	79.93	72.24	35.26	58.89
Total Current Assets	1,199	1,144	1,477	1,678	202.44	191.5
Property, Plant & Equipment	1,790	1,795	1,216	818.35	534.11	510.65
Long-Term Investments	-	-	0.1	-	-	-
Other Intangible Assets	3.95	4.51	3.7	3.65	2.31	0.8
Long-Term Deferred Tax Assets	9.56	10.92	6.61	3.14	-	11.11
Other Long-Term Assets	185.69	163.62	142.29	87.55	75.44	58.03
Total Assets	3,187	3,118	2,846	2,590	814.3	772.09
Accounts Payable	281.79	117.36	88.79	62.87	32.78	15.81
Accrued Expenses	-	86.29	85.32	71.81	53.1	48.43
Short-Term Debt	-	-	-	-	-	12.94
Current Portion of Leases	133.56	127.72	90.45	70.82	58.1	50.3
Current Income Taxes Payable	44.44	39.17	30.55	20.9	20.43	20.2
Current Unearned Revenue	438.53	405.76	400.82	403.31	288.76	301.62
Other Current Liabilities	10.33	88.69	70.04	75.69	45.75	43.23
Total Current Liabilities	908.65	864.98	765.97	705.4	498.92	492.53
Long-Term Leases	526.05	530.33	371.01	234.29	148.89	149.1
Long-Term Deferred Tax Liabilities	0.19	-	-	-	1.37	14.28
Other Long-Term Liabilities	3.34	3.34	3.34	3.36	3.38	3.93
Total Liabilities	1,441	1,401	1,143	944.5	653.79	660.85
Common Stock	110	110	110	110	80	80
Additional Paid-In Capital	1,415	1,415	1,415	1,415	12.29	12.29
Retained Earnings	212.09	203.03	188.92	131.85	79.49	30.23
Comprehensive Income & Other	1.13	-11.27	-11.27	-11.27	-11.27	-11.27
Total Common Equity	1,738	1,717	1,703	1,646	160.5	111.25
Minority Interest	7.93	0	-	-	-	-
Shareholders' Equity	1,746	1,717	1,703	1,646	160.5	111.25
Total Liabilities & Equity	3,187	3,118	2,846	2,590	814.3	772.09
Total Debt	659.62	658.04	461.46	305.1	206.99	212.34
Net Cash (Debt)	129.64	120.5	707.02	1,159	-131.08	-203.06
Net Cash Growth	-54.37%	-82.96%	-39.02%	-	-	-
Net Cash Per Share	0.59	0.55	3.21	6.83	-0.82	-1.27
Filing Date Shares Outstanding	217.71	220	220	220	160	160
Total Common Shares Outstanding	217.71	220	220	220	160	160
Working Capital	289.92	279.22	711.32	972.16	-296.48	-301.03
Book Value Per Share	7.98	7.80	7.74	7.48	1.00	0.70
Tangible Book Value	1,734	1,712	1,699	1,642	158.2	110.45
Tangible Book Value Per Share	7.97	7.78	7.72	7.46	0.99	0.69
Buildings	-	322.49	240.73	184.81	128.06	110.83
Machinery	-	1,387	989.11	711.57	514.16	488.8
Construction In Progress	-	9.17	17.43	11.2	13.29	0.71

Source: S&P Global Market Intelligence. Standard template. Financial Sources.